Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biagio De Angelis

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Gene therapy to improve migration of T cells to the tumor siteAntonio Di Stasi, Biagio De Angelis, Barbara Savoldo
Cells|December 30, 2020
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell ImmunotherapyMarsha Pellegrino, Francesca Del Bufalo, Biagio De Angelis, et al.
Seminars in Hematology|December 1, 2020
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdlesSimona Caruso, Biagio De Angelis, Simona Carlomagno, et al.
Cancers|August 27, 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic ApproachesMatteo Caforio, Emmanuel de Billy, Biagio De Angelis, et al.
Frontiers in Pharmacology|September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue SarcomasMatteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.
Frontiers in Immunology|June 24, 2021
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?Concetta Quintarelli, Antonio Camera, Roselia Ciccone, et al.
Journal of Materials Chemistry. B|February 19, 2020
Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumoursBiagio De Angelis, Nicoletta Depalo, Francesca Petronella, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain CancersClara Guido, Clara Baldari, Gabriele Maiorano, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Frontiers in Immunology|April 7, 2023
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumorsGiada Del Baldo, Francesca Del Bufalo, Claudia Pinacchio, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Gene therapy to improve migration of T cells to the tumor siteAntonio Di Stasi, Biagio De Angelis, Barbara Savoldo
Cells|December 30, 2020
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell ImmunotherapyMarsha Pellegrino, Francesca Del Bufalo, Biagio De Angelis, et al.
Seminars in Hematology|December 1, 2020
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdlesSimona Caruso, Biagio De Angelis, Simona Carlomagno, et al.
Cancers|August 27, 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic ApproachesMatteo Caforio, Emmanuel de Billy, Biagio De Angelis, et al.
Frontiers in Pharmacology|September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue SarcomasMatteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.
Frontiers in Immunology|June 24, 2021
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?Concetta Quintarelli, Antonio Camera, Roselia Ciccone, et al.
Journal of Materials Chemistry. B|February 19, 2020
Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumoursBiagio De Angelis, Nicoletta Depalo, Francesca Petronella, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain CancersClara Guido, Clara Baldari, Gabriele Maiorano, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Frontiers in Immunology|April 7, 2023
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumorsGiada Del Baldo, Francesca Del Bufalo, Claudia Pinacchio, et al.
Pageof 7